Simcere is a leading provider of precision medicine solutions in China, dedicated to building a more accurate, comprehensive, fast and accessible precision medicine infrastructure in critical areas of human health challenges. Through continuous technological innovation, Simcere has a comprehensive pipeline of innovative products in the therapeutic areas of oncology, central nervous system, infection and pharmacogenomics, including Onco500, China's first pan-cancer companion diagnostic product in NGS that has entered clinical trials. Simcere also provides precision medicine service system and digital infrastructure for medical institutions and pharmaceutical companies to enhance the quality, efficiency and experience of precision medicine.